Home › Funds › Zeit Capital LLC › SOLV

Zeit Capital LLC position in SOLV

Solventum Corp · Health Care

Zeit Capital LLC reported holding 150 shares of SOLV (Solventum Corp) in its Q2 2026 13F filing — a position valued at US$12K, representing 0.01% of its reported portfolio and ranking #45 among its reported holdings. Zeit Capital LLC has disclosed SOLV holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)150 sh
Reported value held$11.57K
Portfolio Weight0.01%
First reportedQ1 2026
Last changeNew

How Zeit Capital LLC's SOLV position evolved

Zeit Capital LLC first disclosed a stake in SOLV in Q1 2026 at 150 shares (US$10K). The position peaked in Q2 2026 at 150 shares, worth US$12K. Across 2 filings, Zeit Capital LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 150 shares valued at US$12K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 150 $9.79K New
Q2 2026 150 $11.57K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (Solventum Corp) is a Health Care company. 45 other funds we track also report a position in SOLV — the largest reported positions include Vanguard Group (US$1.35B), Independent Franchise Partners LLP (US$1.25B), BlackRock Inc (US$753.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →